Healthy Blue does cover GLP-1 medications, but what gets approved depends on your state, your diagnosis, and the specific drug. GLP-1s prescribed for type 2 diabetes are covered across every state where Healthy Blue operates. For weight management, coverage is available to members in North Carolina and Kansas with prior authorization, and is not available to members in Louisiana or South Carolina.
GLP-1 Coverage for Type 2 Diabetes
If your prescription is for type 2 diabetes, Healthy Blue covers it in every state the plan serves. This isn’t a matter of plan policy. Under the Medicaid Drug Rebate Program, state Medicaid programs must cover FDA-approved drugs for medically accepted indications, and GLP-1s are FDA-approved for type 2 diabetes.1KFF. Medicaid Coverage of and Spending on GLP-1s
In Louisiana, for example, the state’s clinical criteria require a confirmed diabetes diagnosis and a hemoglobin A1C of 6.5% or higher documented within the previous six months. Members who want a non-preferred GLP-1 agent must show that preferred products failed, caused intolerable side effects, or are contraindicated.2Louisiana Medicaid. GLP-1 and A1C Clinical Authorization Criteria Drugs like Ozempic, prescribed for diabetes, were unaffected by any of the recent weight-management coverage changes in states that did roll those back.3Healthy Blue NC Provider News. Coverage for GLP-1s for the Treatment of Obesity Ends October
GLP-1 Coverage for Weight Management in North Carolina
Healthy Blue North Carolina currently covers GLP-1 medications for weight management, following a short gap in coverage. NC Medicaid first added GLP-1s for obesity on August 1, 2024, then ended that coverage effective October 1, 2025, because of a $319 million Medicaid budget shortfall.4NC DHHS Medicaid. NC Medicaid Change Coverage GLP-1 Weight Management Medications On December 10, 2025, Governor Josh Stein directed NCDHHS to restore the coverage, and the reinstatement took effect December 12, 2025.5NC DHHS Medicaid. NC Medicaid Reinstitute Coverage GLP-1s Weight Management Healthy Blue NC confirmed the restoration on its provider news page.6Healthy Blue NC Provider News. Coverage Restored for GLP-1s for Weight Management
Which Drugs Are on the List
Three medications are back on the Preferred Drug List for weight management. Wegovy (semaglutide) is the preferred product, meaning it can be approved without trying another GLP-1 first. Zepbound (tirzepatide) and Saxenda (liraglutide) are non-preferred: members must first try and fail Wegovy, or the prescriber must document a medical reason Wegovy cannot be used.
Prior Authorization Criteria
Every GLP-1 weight management prescription through Healthy Blue NC requires prior authorization. The clinical thresholds come from NC Medicaid’s outpatient pharmacy criteria:7Healthy Blue NC. GLP-1s for Weight Management Prior Approval Form8NCTracks. NC Medicaid Outpatient Pharmacy Prior Approval Criteria – Weight Management
- Adults 18 and older need a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition such as hypertension, type 2 diabetes, obstructive sleep apnea, cardiovascular disease, or dyslipidemia.
- Adolescents aged 12 to 17 need a BMI at or above the 95th percentile for age and sex, or at or above the 85th percentile with a severe weight-related condition. Zepbound is not approved for anyone under 18.
- Adults 45 and older with cardiovascular disease qualify at a BMI of 27 or higher with a documented history of heart attack, stroke, or symptomatic peripheral arterial disease.
- The patient must be actively participating in structured nutrition and physical activity programs.
- The patient must not be pregnant or breastfeeding and must have no history of medullary thyroid cancer or multiple endocrine neoplasia type 2.
Baseline weight and BMI must be measured within 45 days of the prior authorization request. Initial approval runs six months, and renewals run 12 months with no cap on how many times they can be renewed.
What Renewal Requires
To stay on a GLP-1 for weight management, adults must have lost at least 5% of their pre-treatment weight, and adolescents must show a BMI reduction of more than 4%. A prescriber can still make the case for a patient who falls short by documenting a significant BMI reduction and maintained weight loss.7Healthy Blue NC. GLP-1s for Weight Management Prior Approval Form
GLP-1 Coverage for Weight Management in Kansas
Kansas Medicaid covers GLP-1s for weight management, and Healthy Blue Kansas processes those claims with prior authorization. The state’s anti-obesity medication PA form lists Saxenda, Wegovy, and Zepbound as covered agents.9Kansas KDHE. Anti-Obesity Medications PA Form On the Kansas Preferred Drug List, Wegovy and Wegovy HD are preferred; Zepbound and Saxenda are non-preferred and require additional authorization.10Kansas KDHE. Kansas Preferred Drug List Kansas also requires the patient’s treatment plan to include comprehensive lifestyle interventions covering diet, physical activity, and behavioral therapy.
Louisiana and South Carolina: No Weight-Loss Coverage
Healthy Blue Louisiana covers GLP-1 receptor agonists only for type 2 diabetes. The state’s clinical authorization criteria, effective November 15, 2024, do not include weight management as a covered use.2Louisiana Medicaid. GLP-1 and A1C Clinical Authorization Criteria Pharmacy benefits for Healthy Blue Louisiana are managed by CarelonRx as of October 2025.11Healthy Blue Louisiana. Member Eligibility and Pharmacy
South Carolina Medicaid did cover GLP-1s for weight loss starting November 1, 2024, but reversed that decision effective January 1, 2026, citing $2.3 million in state funds and $5.5 million in federal funds spent on weight-loss prescriptions in the prior fiscal year.12SC Daily Gazette. SC Medicaid Program to Stop Covering Expensive Weight Loss Drugs for Obesity Coverage for type 2 diabetes continues.
These exclusions are allowed because of a longstanding statutory exception that lets state Medicaid programs opt out of covering drugs prescribed for weight loss or weight gain.
Other FDA-Approved Uses
Separate from weight management, Healthy Blue NC covers Wegovy and Zepbound for additional FDA-approved indications, and these did not lose coverage during the 2025 gap:
- Wegovy for reducing the risk of major cardiovascular events in adults 45 and older with established cardiovascular disease and obesity or overweight, and for treating noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver fibrosis.
- Zepbound for treating moderate to severe obstructive sleep apnea in adults with obesity.
Each of these indications has its own prior authorization criteria and form.13Healthy Blue NC. Wegovy and Zepbound Prior Approval Form
How to Confirm Your Coverage
Because state Medicaid rules on GLP-1s have shifted repeatedly, the safest step before filling a prescription is to call Healthy Blue’s member services line for your state and ask whether your specific drug is covered for your specific diagnosis. A prescriber’s office can also submit the prior authorization request and confirm the current clinical criteria. Your pharmacist can tell you whether the drug comes back as covered when they run the claim, which is often the fastest confirmation available.